Molecular Sensing
Nashville
About Molecular Sensing
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments ’ no tags or tethering
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2020)
- Website: molsense.com
- Phone: (615)938-7050
Industries & Categories
Biotechnology, Collaboration, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/molecular-sensing-2202461 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.